Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: Requirement for phosphatidylinositol 3-kinase activity

Cell Growth and Differentiation

Volumn 11, Issue 2, 2000, Pages 123-133

  Qiao, Hui ^a   Saulnier, Ronald ^a,b   Patryzkat, Alexander ^a   Rahimi, Nader ^a,c   Raptis, Leda ^a   Rossiter, John ^a   Tremblay, Eric ^a   Elliott, Bruce ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SERINE;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL ADHESION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; CHROMONES; CULTURE MEDIA, SERUM-FREE; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; FIBRONECTINS; HEPATOCYTE GROWTH FACTOR; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MORPHOLINES; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0034014356     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Boudreau, N., Werb, Z., and Bissell, M. J. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA, 93: 3509-3513, 1996.
2. Petersen, O. W., Ronnov-Jessen, L., Hewlett, A. R., and Bissell, M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA, 89: 9064-9068, 1992.
3. Wewer, U. M., Shaw, L. M., Albrechtsen, R., and Mercurio, A. M. The integrin α6 β1 promotes the survival of metastatic human breast carcinoma cells in mice. Am. J. Pathol., 151: 1191-1198, 1997.
4. Hewlett, A. R., Bailey, N., Damsky, C., Petersen, O. W., and Bissell, M. Cellular growth and survival are mediated by β1 integrins in normal human breast epithelium but not in breast carcinoma. J. Cell Sci., 108: 1945-1957, 1995.
5. Boyer, B., Valles, A. M., and Thiery, J. P. Model systems of epithelium-mesenchyme transitions. Acta Anat., 156: 227-239, 1996.
6. Tuck, A. B., Park, M., Sterns, E. E., Boag, A., and Elliott, B. E. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol., 148: 225-232, 1996.
7. Wang, Y., Selden, A. C., Morgan, N., Stamp, G. W., and Hodgson, H. J. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am. J. Pathol., 144: 675-682, 1994.
8. Jin, L., Fuchs, A., Schnitt, S. J., Yao, Y., Joseph, A., Lamszus, K., Park, M., Goldberg, I. D., and Rosen, E. M. Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (Phila.), 79: 749-760, 1996.
9. Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., and Shin, S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54: 1630-1633, 1994.
10. Ghoussoub, R. A. D., Dillon, D. A., D'Aquila, T., Rimm, E. B., Fearon, E. R., and Rimm, D. L. Expression of c-Met is a strong independent prognostic factor in breast cancer. Cancer (Phila.), 82: 1513-1520, 1998.
11. Liang, T. J., Reid, A. E., Xavier, R., Cardiff, R. D., and Wang, T. C. Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. J. Clin. Investig., 97: 2872-2877, 1996.
12. Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., and Merlino, G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA, 94: 701-706, 1997.
13. Jeffers, M., Rong, S., Anver, M., and Vande Woude, G. F. Autocrine hepatocyte growth factor/scatter factor-Met signalling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene, 13: 853-856, 1996.
14. Bellusci, S., Moens, G., Gaudino, G., Comoglio, P., Nakamura, T., Thiery, J. P., and Jouanneau, J. Creation of an hepatocyte growth factor/ scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene, 9: 1091-1099, 1994.
15. Fixman, E. D., Naujokas, M. A., Rodrigues, G. A., Moran, M. F., and Park, M. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. Oncogene, 10: 237-249, 1995.
16. Byers, S., Park, M., Sommers, C., and Seslar, S. Breast carcinoma: a collective disorder. Breast Cancer Res. Treat., 31: 203-215, 1994.
17. Amicone, L., Spagnoli, F. M., Spath, G., Giordano, S., Tommasini, C., Bernardini, S., De Luca, V., Della Rocca, C., Weiss, M. C., Comoglio, P. M., and Tripodi, M. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J., 16: 495-503, 1997.
18. Liu, Y., Sun, A. M., and Dworkin, L. D. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem. Biophys. Res. Commun., 246: 821-826, 1998.
19. Fan, S., Wang, J. A., Yuan, R. Q., Rockwell, S., Andres, J., Zlatapolskiy, A., Goldberg, I. D., and Rosen, E. M. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene, 17: 131-141, 1998.
20. Zhang, Z., Vuori, K., Reed, J., and Ruoslahti, E. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA, 92: 6161-8165, 1995.
21. Frisch, S. M., and Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol., 9: 701-706, 1997.
22. Boudreau, N., Sympson, C. J., Werb, Z., and Bissell, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Washington DC), 267: 891-893, 1995.
23. Montgomery, A. M., Reisfeld, R. A., and Cheresh, D. A. Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA, 91: 8856-8860, 1994.
24. Wang, F., Weaver, V. M., Petersen, O. W., Larabell, C. A., Dedhar, S., Briand, P., Lupu, R., and Bissell, M. J. Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl. Acad. Sci. USA, 95: 1421-1426, 1998.
25. Damsky, C. H., and Werb, Z. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr. Opin Cell Biol., 4: 772-781, 1992.
26. Moro, L., Venturino, M., Bozzo, C., Silengo, L., Altruda, F., Beguinot, L., Tarone, G., and Defilippi, P. Integrins induce activation of EGF receptor: role in MAP kinase and adhesion-dependent cell survival. EMBO J., 17: 6622-6632, 1998.
27. Bourguignon, L. Y., Zhu, H., Chu, A., Iida, N., Zhang, L., Hung, M. C. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J. Biol. Chem., 272: 27913-27918, 1997.
28. Rahimi, N., Tremblay, E., McAdam, L., Park, M., Schwall, R., and Elliott, B. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ., 7: 263-270, 1996.
29. Saulnier, R., Bhardwaj, B., Klassen, J., Leopold, D., Rahimi, N., Tremblay, E., Mosher, D., and Elliott, B. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma. Exp. Cell Res., 222: 360-369, 1996.
30. Rahimi, N., Tremblay, E., and Elliott, B. Phosphatidylinositol 3-kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells. J. Biol. Chem., 271: 24850-24855, 1996.
31. Skouteris, G. G., and Georgakopoulos, E. Hepatocyte growth factor-induced proliferation of primary hepatocytes is mediated by activation of Phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun., 218: 229-233, 1996.
32. Ptasznik, A., Beattie, G. M., Mally, M. I., Cirulli, V., Lopez, A., and Hayek, A. Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation. J. Cell Biol., 137: 1127-1136, 1997.
33. Royal, I., and Park, M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem., 270: 27780-27787, 1995.
34. Shaw, L. M., Rabinovitz, I., Wang, H. H., Toker, A., and Mercurio, A. M. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell, 91: 949-960, 1997.
35. Yao, R., and Cooper, G. M. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity. Oncogene, 13: 343-351, 1996.
36. Webster, M. A., Hutchinson, J. N., Rauh, M. J., Muthuswamy, S. K., Anton, M., Tortorice, C. G., Cardiff, R. D., Graham, F. L., Hassell, J. A., and Muller, W. J. Requirement tor both Shc and phosphatidylinositol 3-kinase signalling pathways in polyoma middle T-mediated mammary tumorigenesis. Mol. Cell. Biol., 18: 2344-2359, 1998.
37. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11: 701-713, 1997.
38. Rahimi, N., Hung, W., Saulnier, R., Tremblay, E., and Elliott, B. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells. J. Biol. Chem., 273: 33714-33721, 1998.
39. Wang, R., Kobayashi, R., and Bishop, J. M. Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor. Proc. Natl. Acad. Sci. USA, 93: 8425-8430, 1996.
40. 1 integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGF β-receptors. J. Cell Biol., 132: 741-752, 1996.
41. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269: 5241-5248, 1994.
42. Wennstrom, S., and Downward, J. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. J. Cell Biol., 19: 4279-4288, 1999.
43. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H., and Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J., 16: 2783-2793, 1997.
44. Pang, L., Sawada, T., Decker, S. J., and Saltiel, A. R. Inhibition of MAPK kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem., 270: 13585-13588, 1995.
45. Fabregat, I., Sanchez, A., Alvarez, A., Nakamura, T., and Benito, M. Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor-β in fetal hepatocytes in primary culture. FEBS Lett., 384: 14-18, 1996.
46. Dangles, V., Femenia, F., Laine, V., Berthelemy, M., Le Rhun, D., Poupon, M. F., Levy, D., and Schwartz-Cornil, I. Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines. Cancer Res., 57: 3360-3364, 1997.
47. Liu, Y. C., Chen, S. C., Chang, C., Leu, C. M., and Hu, C. P. Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines. Exp. Cell Res., 228: 206-211, 1996.
48. Mizuno, K., Higuchi, O., Tajima, H., Yonemasu, T., and Nakamura, T. Cell density-dependent regulation of hepatocyte growth factor receptor on adult rat hepatocytes in primary culture. J. Biochem., 114: 96-102, 1993.
49. Mars, W. M., Zarnegar, R., and Michalopoulos, G. K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol., 143: 949-958, 1995.
50. Chernousov, M. A., Fogerty, F. J., Koteliansky, V. E., and Mosher, D. F. Role of the I-9 and III-1 modules of fibronectin in formation of an extracellular fibronectin matrix. J. Biol. Chem., 266: 10851-10858, 1991.
51. + antiporter by platelet-derived growth factor. Proc. Natl. Acad. Sci. USA, 89: 6138-6141, 1992.
52. Miyamoto, S., Teramoto, H., Gutkind, J. S., and Yamada, K. M. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol., 135: 1633-1642, 1996.
53. McNamee, H. P., Ingber, D. E., and Schwartz, M. A. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J. Cell Biol., 121: 673-678, 1993.
54. Klippel, A., Escobedo, M. A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., and Williams, L. T. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol., 18: 5699-5711, 1998.
55. Schlottmann, K. E., Gulbins, E., Lau, S. M., and Coggeshall, K. M. Activation of Src-family tyrosine kinases during Fas-induced apoptosis. J. Leuk. Biol., 60: 546-554, 1996.
56. Richardson, A., Malik, R. K., Hildebrand, J. D., and Parsons, J. T. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by co-expression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol. Cell. Biol, 17: 6906-6914, 1997.
57. Yamada, K., and Geiger, B. Molecular interactions in cell adhesion complexes. Curr. Opin. Cell Biol., 9: 76-85, 1997.
58. Roskelley, C. D., and Bissell, M. J. Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function. Biochem. Cell Biol., 73: 391-397, 1995.
59. Matsumoto, K., Nakamura, T., and Kramer, R. H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem., 269: 31807-31813, 1994.
60. Frisch, S. M., Vuori, K., Ruoslahti, E., and Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol., 134: 793-799, 1996.
61. Hannigan, G. E., and Dedhar, S. Protein kinase mediators of integrin signal transduction. J. Mol. Med., 75: 35-44, 1997.
62. Glinsky, G. V. Apoptosis in metastatic cancer cells. Crit. Rev. Oncol. Hematol., 25: 175-186, 1997.
63. Elliott, B. E., Tam, S. P., Dexter, D., and Chen, Z. Q. Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int. J. Cancer, 51: 416-424, 1992.
64. Elliott, B. E., Maxwell, L., Arnold, M., Wei, W. Z., and Miller, F. R. Expression of epithelial-like markers and class I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: orthotopic site effects. Cancer Res., 48: 7237-7245, 1988.
65. Mukhopadhyay, D., Tsiokas, L., Zhou, X. M., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
66. Rossiter, J. P., Riopelle, R. J., and Bisby, M. A. Axotomy-induced apoptotic cell death of neonatal rat facial motoneurons: time course analysis and relation to NADPH-diaphorase activity. Exp. Neurol., 138: 33-44, 1996.
67. Tsangaris, G. T., and Tzortzatou-Stathopoulou, F. Development of a quantitative method for the study of apoptosis in peripheral blood. In Vivo, 10: 435-443, 1996.